The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Perioral Dermatitis

Acneiform-rosacea-like eruption around the mouth: pathogenesis, triggers, and treatment

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →

What is Perioral Dermatitis?

Perioral dermatitis (POD), also called periorificial dermatitis when extending around eyes/nose, predominantly affects women aged 20-45 (90% female) and prepubertal children. Pathogenesis is multifactorial: prolonged topical corticosteroid use (most common trigger), fluorinated toothpaste, occlusive cosmetics, hormonal influences, demodex mites, possible candidal involvement.

Clinical features: clusters of small (1-2 mm) erythematous papules, papulopustules, and occasional vesicles around the mouth, with characteristic CLEAR ZONE around the vermilion border (1-5 mm). Periocular variant affects lateral canthi and lower eyelids. Granulomatous variant in children: yellow-brown papules. Differential: acne (comedones present, not in POD), rosacea (telangiectasia), seborrheic dermatitis (scaling).

Treatment: stop ALL topical corticosteroids (paradoxical worsening initially - 'flare reaction'), avoid heavy moisturizers/cosmetics, gentle cleansing only. Mild cases: topical metronidazole, erythromycin, azelaic acid, pimecrolimus, ivermectin. Moderate-severe: oral tetracyclines (doxycycline 100 mg/day, or minocycline) for 6-12 weeks. Children: erythromycin, azithromycin (avoid tetracyclines under age 8). Resolution typically in 4-12 weeks; recurrences common with corticosteroid re-exposure.

Symptoms

Cluster of small erythematous papules around the mouth
Papulopustules (small pustules within papules)
Burning, stinging, or mild itching
Characteristic clear zone around vermilion border (pathognomonic)
Possible extension to nasolabial folds, chin, periocular
Worsening with topical corticosteroids (paradoxical)
Granulomatous variant: yellow-brown firm papules (children)
Lupus miliaris disseminatus faciei variant (granulomatous)
No comedones (distinguishes from acne)

Risk Factors

Topical corticosteroid use (most important - facial application)
Inhaled or systemic corticosteroids (less common)
Female gender (90%)
Age 20-45 in adults, prepubertal in children
Heavy moisturizer or sunscreen use
Fluoride toothpaste (suspected)
Hormonal contraceptives (variable)
Cosmetic use (especially occlusive)
Demodex folliculorum (proposed)
Atopic background

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent papular rash around mouth not responding to OTC treatment
  • Worsening rash after topical corticosteroid use
  • Cluster of small bumps with clear zone around lips
  • New facial rash in young woman or child
  • Recurrent facial rash with corticosteroid use
  • Failed acne treatment (POD often misdiagnosed as acne)
  • Periocular involvement
  • Granulomatous-appearing facial papules

Treatment Methods

01
STOP ALL TOPICAL CORTICOSTEROIDS (most important step)
02
Discontinue heavy cosmetics, moisturizers, sunscreens
03
Gentle cleansing (mild non-soap cleanser, water)
04
Topical metronidazole 0.75% gel/cream BID (8-12 weeks)
05
Topical erythromycin 2% gel BID
06
Topical azelaic acid 15% gel BID
07
Topical pimecrolimus 1% cream BID (calcineurin inhibitor)
08
Topical ivermectin 1% cream daily
09
Oral doxycycline 100 mg/day (6-12 weeks - first-line moderate-severe)
10
Oral minocycline 50-100 mg/day (alternative)
11
Oral erythromycin 250-500 mg BID (children, pregnancy)
12
Oral isotretinoin (low-dose - refractory cases)
13
Patient education: trigger avoidance, expectation of slow resolution
14
Anticipatory guidance: 'flare reaction' after stopping corticosteroids
15
Avoid switching to lower-potency corticosteroid (perpetuates POD)
16
Gradual reintroduction of skincare after resolution
17
Recurrence prevention: avoid topical steroids on face

Which Department to Visit?

You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dermatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Eczema (Atopic Dermatitis)

Dermatoloji

Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.

Psoriasis

Dermatoloji

Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.

Acne

Dermatoloji

Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.

Rosacea

Dermatoloji

Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.

Urticaria (Hives)

Dermatoloji

Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.

Skin Fungal Infections

Dermatoloji

Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.

Hair Loss (Alopecia)

Dermatoloji

Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.

Vitiligo

Dermatoloji

Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.